Prevalence

NIAID-Supported Study Suggests That Eczema and Egg Allergy May Precede Peanut Allergy

Early results from the NIAID-supported Learning Early About Peanut Allergy (LEAP) study show that severe eczema and egg allergy strongly predict risk for peanut allergy. These results may help identify infants who could most benefit from strategies aimed at preventing peanut allergy. 

The LEAP study, led by investigators in the United Kingdom, seeks to determine if introducing peanuts early in a child’s diet could prevent future peanut allergy.

Eczema prevalence in the United States: Data from the 2003 National Survey of Children’s Health

Report from the Journal of Investigative Dermatology: Using the 2003 National Survey of Children’s Health sponsored by the federal Maternal and Child Health Bureau, we calculated prevalence estimates of eczema nationally and for each state among a nationally representative sample of 102,353 children 17 years of age and under.

U.S. Eczema Prevalence Study of Children 17 and Younger

In this study, Tatyana E. Shaw, Gabriel P. Currie, Caroline W. Koudelka, and Eric L. Simpson of the Oregon Health & Sciences University, Department of Dermatology, calculated estimates of pediatric eczema population throughout the United States.